Novobiocin inhibits vaccinia virus replication by blocking virus assembly.
Novobiocin inhibits the replication of vaccinia virus in cultured BSC40 cells. All classes of viral proteins were synthesized during synchronous infection in the presence of drug. The onset of DNA replication was delayed slightly, yet the extent of DNA replication in the presence of novobiocin was comparable to that of a control infection. A delay in the temporal transition to late viral protein synthesis was in keeping with the effects on DNA replication. Although the precursor forms of the major viral structural proteins were synthesized normally at late times, the proteolytic processing of these polypeptides was inhibited, which suggested an impediment to virus assembly. Electron microscopy revealed that novobiocin blocked virus morphogenesis at an early stage. Conversion of the concatemeric DNA replication intermediates into hairpin telomeres occurred in the presence of novobiocin, confirming that telomere resolution was not coupled to virus assembly. Novobiocin is the latest addition to a class of antipoxviral agents, which includes rifampin and IMCBH, that arrest morphogenesis.
Sekiguchi
J
J
Program in Molecular Biology, Sloan-Kettering Institute, New York, New York 10021, USA.
Shuman
S
S
D000818:Animals; D000998:Antiviral Agents; D002460:Cell Line; D004261:DNA Replication; D009024:Morphogenesis / Q000187:drug effects; D009675:Novobiocin / Q000494:pharmacology*; D016615:Telomere; D014616:Vaccinia virus / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D010948:Viral Plaque Assay; D014764:Viral Proteins / Q000096:biosynthesis / Q000187:drug effects / Q000302:isolation & purification; D015678:Viral Structural Proteins / Q000096:biosynthesis; D014771:Virion / Q000187:drug effects / Q000502:physiology; D014779:Virus Replication / Q000187:drug effects*
D000998:Antiviral Agents; D014764:Viral Proteins; D015678:Viral Structural Proteins; D009675:Novobiocin